Filter your results
- 3
- 1
- 4
- 4
- 1
- 1
- 2
- 4
- 3
- 1
- 1
- 4
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
|
FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cellsSTAR Protocols, 2022, 3 (4), pp.101680. ⟨10.1016/j.xpro.2022.101680⟩
Journal articles
hal-04060050v1
|
||
From Human-Induced Pluripotent Stem Cells to Liver Disease Modeling: A Focus on DyslipidemiaCurrent Pathobiology Reports, 2015, Equipe 5, 3 (1), pp.47--56. ⟨10.1007/s40139-015-0067-1⟩
Journal articles
hal-01830981v1
|
|||
|
PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCsStem Cell Reports, 2021, ⟨10.1016/j.stemcr.2021.10.004⟩
Journal articles
hal-03451184v1
|
||
|
Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemiaDisease Models & Mechanisms, 2015, ⟨10.1242/dmm.022277⟩
Journal articles
hal-01233240v1
|